Turning science into business: An optimised alternative to antibodies
Drug Discovery World
APRIL 3, 2023
From humble beginnings in the founder’s basement, UK-based Aptamer Group is now supplying its Optimer binders to clients across big pharma. Addressing this need in the market has allowed us penetration to work with 75% of the top twenty pharma companies. DDW’s Diana Spencer caught up with co-founder and CEO Dr Arron Tolley.
52 
Let's personalize your content